Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.42 |
| ▸ | HTR6 | P50406 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21308005 | 0.84 | CA2 (0.35) | KDM4EALDH1A1ENPP2 | |
| SCHEMBL3789991 | 0.84 | CA2 (0.35) | KDM4EALDH1A1ENPP2HTR6 | |
| SCHEMBL3781727 | 0.79 | KDM4E (0.38) | KDM4EALDH1A1ENPP2 | |
| SCHEMBL190209 | 0.77 | ENPP2 (0.56) | KDM4EALDH1A1ENPP2 | |
| SCHEMBL13677416 | 0.77 | HTR6 (0.42) | KDM4EALDH1A1HTR6 | |
| SCHEMBL12990555 | 0.77 | HTR6 (0.47) | KDM4EALDH1A1HTR6 | |
| SCHEMBL3786835 | 0.71 | ALDH1A1 (0.57) | KDM4EALDH1A1ENPP2 | |
| SCHEMBL10209998 | 0.71 | KDM4E (0.49) | KDM4EALDH1A1 | |
| SCHEMBL12991010 | 0.69 | ALDH1A1 (0.60) | KDM4EALDH1A1HTR6 | |
| SCHEMBL3789580 | 0.69 | ENPP2 (0.48) | KDM4EALDH1A1ENPP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100087680-A1 | METHOD FOR PRODUCING BIARYL COMPOUND | SUMITOMO CHEMICAL COMPANY LIMITED (JP) | 2010-04-08 | — | — | US | disclosed |
| EP-1914221-A1 | PROCESS FOR PRODUCING BIARYL COMPOUND | Sumitomo Chemical Company, Limited (JP) | 2008-04-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100087680-A1 | METHOD FOR PRODUCING BIARYL COMPOUND | NISCH, BLVRB, BBOX1 | KDM4E 2606/4885ALDH1A1 4339/4885ENPP2 1920/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.